Cargando…

Secondary hyperparathyroidism among Nigerians with chronic kidney disease

BACKROUND: Secondary hyperparathyroidism (SHPT) is a manifestation of chronic kidney disease mineral bone disorder (CKD-MBD). SHPT is common in patients with chronic kidney disease (CKD) and is associated with significant morbidity and mortality. METHODS: A cross- sectional descriptive study involvi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gimba, Zumnan M, Abene, Esala E, Agbaji, Oche O O, Agaba, Emmanuel I
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Makerere Medical School 2018
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6306980/ https://www.ncbi.nlm.nih.gov/pubmed/30602972 http://dx.doi.org/10.4314/ahs.v18i2.30

Ejemplares similares

Practice of Hemodialysis in a Resource-Poor Setting in Nigeria: A 2-Year Experience
por: Abene, Esala Ezekiel, et al.
Publicado: (2017)

Obesity and obstructive sleep apnea risk among Nigerians
por: Akanbi, Maxwell O., et al.
Publicado: (2017)

Long Term Exposure to Tenofovir Disoproxil Fumarate-Containing Antiretroviral Therapy Is Associated with Renal Impairment in an African Cohort of HIV-Infected Adults
por: Agbaji, Oche O., et al.
Publicado: (2019)

A survey of non-communicable diseases and their risk factors among university employees: a single institutional study
por: Emmanuel, I Agaba, et al.
Publicado: (2017)

Sexual Functioning and Health-related Quality of Life in Men
por: Agaba, Patricia A., et al.
Publicado: (2017)

Secondary Hyperparathyroidism in Chronic Kidney Disease: Pathophysiology and Management
por: Habas, Elmukhtar, et al.
Publicado: (2021)

Oral Paricalcitol for the Treatment of Secondary Hyperparathyroidism in Chronic Kidney Disease
por: Cheng, Steven, et al.
Publicado: (2006)

Parathyroid Cell Proliferation in Secondary Hyperparathyroidism of Chronic Kidney Disease
por: Naveh-Many, Tally, et al.
Publicado: (2020)

Predictors of impaired renal function among HIV infected patients commencing highly active antiretroviral therapy in Jos, Nigeria
por: Agbaji, Oche O., et al.
Publicado: (2011)

A 33-year-old patient with human immunodeficiency virus on antiretroviral therapy with efavirenz-induced complex partial seizures: a case report
por: Shehu, Nathan Yakubu, et al.
Publicado: (2016)

Association of Secondary Hyperparathyroidism with Hemoglobin Level in Patients with Chronic Kidney Disease
por: Chutia, Happy, et al.
Publicado: (2013)

Recent advances in understanding and managing secondary hyperparathyroidism in chronic kidney disease
por: Rodríguez-Ortiz, María E., et al.
Publicado: (2020)

Secondary and Tertiary Hyperparathyroidism in Chronic Kidney Disease: An Endocrine and Renal Perspective
por: Chandran, Manju, et al.
Publicado: (2019)

Secondary hyperparathyroidism and adverse health outcomes in adults with chronic kidney disease
por: Xu, Yang, et al.
Publicado: (2021)

Complications after radiofrequency ablation of hyperparathyroidism secondary to chronic kidney disease
por: Lin, Li-Ping, et al.
Publicado: (2023)

Outcomes of Secondary Hyperparathyroidism in Chronic Kidney Disease and the Direct Costs of Treatment
por: Joy, Melanie S., et al.
Publicado: (2007)

Awareness and knowledge of human immunodeficiency virus post exposure prophylaxis among Nigerian Family Physicians
por: Agaba, Patricia A., et al.
Publicado: (2012)

Effectiveness of Cinacalcet in Patients with Chronic Kidney Disease and Secondary Hyperparathyroidism Not Receiving Dialysis
por: Pérez-Ricart, Ariadna, et al.
Publicado: (2016)

Limited usefulness of calcimimetics for secondary hyperparathyroidism in non-dialysis chronic kidney disease
por: Abbas, Fizza, et al.
Publicado: (2019)

Vitamin D prohormone in the treatment of secondary hyperparathyroidism in patients with chronic kidney disease
por: Friedl, Claudia, et al.
Publicado: (2017)

Treatment Outcomes Among Older Human Immunodeficiency Virus-Infected Adults in Nigeria
por: Agaba, Patricia A., et al.
Publicado: (2017)

Comparative incidence of adverse drug reaction during the first and subsequent year of antiretroviral therapy in a Nigerian HIV infected Cohort
por: Abah, Isaac O, et al.
Publicado: (2021)

Drug resistance patterns following pharmacy stock shortage in Nigerian Antiretroviral Treatment Program
por: Meloni, Seema T., et al.
Publicado: (2017)

Pin1 and secondary hyperparathyroidism of chronic kidney disease: gene polymorphisms and protein levels
por: Zhao, Yu, et al.
Publicado: (2016)

Paricalcitol vs. cinacalcet for secondary hyperparathyroidism in chronic kidney disease: A meta-analysis
por: Xu, Wei, et al.
Publicado: (2020)

Evaluation of Therapies for Secondary Hyperparathyroidism Associated with Vitamin D Insufficiency in Chronic Kidney Disease
por: Strugnell, Stephen A., et al.
Publicado: (2023)

Persistent fibroblast growth factor 23 signalling in the parathyroid glands for secondary hyperparathyroidism in mice with chronic kidney disease
por: Kawakami, Kazuki, et al.
Publicado: (2017)

Genetic diversity of Mycobacterium tuberculosis Complex in Jos, Nigeria
por: Ani, Agatha, et al.
Publicado: (2010)

Meta-Analysis: The Efficacy and Safety of Paricalcitol for the Treatment of Secondary Hyperparathyroidism and Proteinuria in Chronic Kidney Disease
por: Han, Tianzhao, et al.
Publicado: (2013)

Efficacy and safety of oral doxercalciferol in the management of secondary hyperparathyroidism in chronic kidney disease stage 4
por: Dheerendra, P. C., et al.
Publicado: (2013)

The Pathophysiology of Secondary Hyperparathyroidism and the Consequences of Uncontrolled Mineral Metabolism in Chronic Kidney Disease: The Role of COSMOS
por: Cannata-Andía, Jorge B., et al.
Publicado: (2008)

Budget impact of secondary hyperparathyroidism treatment in chronic kidney disease in an Ecuadorian social security hospital
por: Manjarres, Luis, et al.
Publicado: (2016)

Population Pharmacokinetics and Pharmacodynamics of the Calcimimetic Etelcalcetide in Chronic Kidney Disease and Secondary Hyperparathyroidism Receiving Hemodialysis
por: Chen, P, et al.
Publicado: (2016)

Long-term effectiveness of cinacalcet in non-dialysis patients with chronic kidney disease and secondary hyperparathyroidism
por: Pérez-Ricart, Ariadna, et al.
Publicado: (2019)

Cost-effectiveness analysis of cinacalcet vs. paricalcitol in the treatment of hyperparathyroidism secondary to chronic kidney disease
por: Ponce, Daniela, et al.
Publicado: (2023)

Awareness level of kidney functions and diseases among adults in a Nigerian population
por: Okwuonu, C. G., et al.
Publicado: (2015)

Degrees of Kidney Disease in Nigerian Adults with Sickle-Cell Disease
por: Aneke, John C., et al.
Publicado: (2014)

Association of Vitamin D and secondary hyperparathyroidism with anemia in diabetic kidney disease
por: Sonkar, Satyendra Kumar, et al.
Publicado: (2018)

Hyperparathyroidism with hypercalcaemia in chronic kidney disease: primary or tertiary?
por: Lunn, Mitchell R., et al.
Publicado: (2010)

Pattern of drug therapy problems and interventions in ambulatory patients receiving antiretroviral therapy in Nigeria
por: Ojeh, Victor B., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ik76pdck7geltnj12tj54pnquo